ProPhase Labs Inc. (PRPH) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for ProPhase Labs Inc. (PRPH:NASDAQ), powered by AI.

Current Price
$0.10
P/E Ratio
-0.0
Market Cap
298,740
Sector
Healthcare
What is the ProPhase Labs Inc. stock price forecast?

ProPhase Labs Inc. is currently trading at $0.10. View real-time AI analysis on Alpha Lenz.

What is ProPhase Labs Inc. insider trading activity?

View the latest insider trading data for ProPhase Labs Inc. on Alpha Lenz.

What is ProPhase Labs Inc.'s P/E ratio?

ProPhase Labs Inc.'s P/E ratio is -0.0.

ProPhase Labs Inc.

NASDAQ · PRPH
$0.10
Ask about ProPhase Labs Inc.'s future dividend policy...
Alpha Chat Insight

ProPhase Labs Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -188.1%.

Ask for details

Company Overview

ProPhase Labs Inc. is a diversified health sciences company engaged in various segments of healthcare and diagnostics. The primary function of ProPhase Labs is to develop, manufacture, and market an array of over-the-counter (OTC) consumer healthcare products. The company has a crucial role in the health and wellness sector by providing innovative solutions for common ailments. Notably, ProPhase Labs also operates within the genetic testing and diagnostics space, offering services that cater to growing demands for personalized medicine and preventive healthcare measures. With a significant presence in both consumer products and advanced diagnostic services, ProPhase Labs impacts sectors ranging from retail healthcare to biotechnology. As a company continually expanding its product lines and diagnostic capabilities, ProPhase Labs positions itself as an integral player in fostering accessible health solutions, thereby enhancing its market significance in the dynamic landscape of healthcare innovation and delivery.

CEOMr. Ted William Karkus
SectorHealthcare
IndustryDiagnostics & Research
Employees96

Company Statistics

FY 2024

Profile

$298.74KMarket Cap
$6.77MRevenue
0.00Shares Out
96Employees

Margins

-2.22%Gross
-472.72%EBITDA
-570.59%Operating
-625.26%Pre-Tax
-788.24%Net

Valuation

-0.01P/E
0.04P/B
0.04EV/Sales
-0.76EV/EBITDA
-0.02P/FCF

Growth (CAGR)

-55.92%Rev 3Yr
-7.27%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-68.80%ROA
-188.11%ROE
-50.26%ROIC

Financial Health

$678.00KCash & Cash Equivalents
$55.17MNet Debt
759.51%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

ProPhase Labs Inc. (ticker: PRPH) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 96 employees. Market cap is $298,740.

The current price is $0.1 with a P/E ratio of -0.01x and P/B of 0.04x.

ROE is -188.11% and operating margin is -570.59%. Annual revenue is $7M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
ProPhase Labs Inc. (Healthcare) Stock Forecast & Analysis $0.10 | Alpha Lenz